PredxBio, Inc., based in Pittsburgh, PA, is a pioneering company at the forefront of spatially intelligent biology, revolutionizing drug discovery and clinical development through their innovative platform technology. Their solutions leverage unbiased spatial analytics and explainable AI to identify novel cell types, biomarkers, and targets, empowering clinicians and researchers to accelerate drug discovery, optimize clinical trials, and personalize therapeutic options.
Led by seasoned healthcare leader B. Dusty Majumdar, PhD, and medical technology expert Joe Camaratta, PredxBio is dedicated to bending the survival curve for immunotherapy cancer patients by providing highly personalized adjuvant therapy options and advanced companion diagnostics. Their precision pathology solutions bring unparalleled flexibility and ease to clinical workflows, addressing unmet pathology needs and transforming the landscape of precision healthcare.
Generated from the website